Most US neurologists treating patients with multiple sclerosis receive industry payments, with higher payments linked to higher prescribing of that company’s drugs, new research shows.

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under ...

The warden fired from Jefferson City Correctional Center after an inmate’s death is suing the state, alleging age, gender, ...

Nearly 80% of U.S. neurologists prescribing drugs for multiple sclerosis (MS) have received at least one pharma industry payment, with higher-volume prescribers more likely to be beneficiaries, finds ...

Jan Janisch-Hanzlik, Dr. Matthew Lunning and Dr. Rana Zabad discuss new multiple sclerosis therapy during a press conference at the Buffett Cancer Center in Omaha on Tuesday, Aug. 5, 2025. When the ...

In a global first, the Emirates Drug Establishment (EDE) has approved Tolebrutinib, the only oral treatment specifically developed to slow disability progression in adults with non-relapsing secondary ...

A previously "hidden" subtype of Multiple Sclerosis (MS)—a condition that affects the brain and spinal cord—has been uncovered. The distinct subtype exhibits "significant cognitive deficits with ...

While the challenges continue, so do the good works done by our neighbors, our teachers, our health care providers, our volunteers and so many others. This is their story. Ledyard National Bank is ...

BRISTOL, R.I. (WJAR) — A Fall River physical education teacher is practicing what she preaches when it comes to fitness, having recently ran 153 miles to help fight multiple sclerosis. Renea ...

A team of scientists led by the Institute for Glial Sciences (IGS) at Case Western Reserve University's School of Medicine has discovered a built-in "brake" that controls when key brain cells mature.